News | February 10, 2015

Study Shows Elevated Cardiovascular Risk for Younger Adults with Isolated Systolic Hypertension

“Top number” alone in blood pressure reading better indicator than previously thought

blood pressure, systolic, hypertension, younger adults, cardiovascular, risk

February 10, 2015 — Younger adults with elevated systolic blood pressure have a higher risk for cardiovascular disease and coronary heart disease than those with normal blood pressure, according to a large long-term study of younger adults published online in the Journal of the American College of Cardiology. The risk was higher for women.

High systolic blood pressure with normal or near normal diastolic blood pressure is known as isolated systolic hypertension.

“Until now, physicians have not considered isolated systolic hypertension to be bad, but this study shows higher risk,” said the study’s lead author Yuichiro Yano, M.D., of the Department of Preventive Medicine at Northwestern University Feinberg School of Medicine in Chicago. “By identifying risks in younger populations, they can be made aware of the need to maintain cardiovascular health as they age.”

Researchers followed nearly 30,000 young and middle-aged adults for more than 30 years. Isolated systolic blood pressure is defined as a systolic blood pressure 140 mm Hg or greater and diastolic blood pressure of less than 90 mm Hg. Normal blood pressure is defined as 130 mm Hg or less over 85 mm Hg or less.

The study included 15,868 men and 11,213 women age 18 to 49, with a mean age of 34 years, from the Chicago Heart Association Detection Project in Industry Study. Given the large number of participants in the Chicago study, researchers from Northwestern, University of Illinois at Chicago and University of California in Irvine believed it was a unique opportunity to study this population.

The subjects were recruited between 1967 and 1973. Of these, 85 percent were non-Hispanic whites without signs of heart disease who were not taking antihypertensive medications. The study found that compared to men who have normal blood pressure, men with high systolic blood pressure had a 23 percent increase in cardiovascular death. Compared to women with normal blood pressure, women with high systolic blood pressure had a 55 percent increase in cardiovascular death.

“We were surprised to find that women with isolated systolic hypertension were not so rare (25 percent of younger and middle-aged adults with isolated systolic hypertension were women),” Yano said. “Their cardiovascular disease risk is higher than we thought it would be.”

One of the reasons the prevalence of isolated systolic hypertension is increasing in the United States is the obesity epidemic. “This study found consistently higher body mass index and cholesterol levels in young and middle-aged adults with isolated systolic hypertension,” Yano reports. “Obesity was not the main focus of this study, but our research resulted in very interesting data.”

The study was an observational study, which means there were no randomized controls and conclusions that can be drawn are limited. “We cannot definitively infer whether the excess cardiovascular disease risk from isolated systolic hypertension in younger and middle-aged adults warrants antihypertensive drug therapy or whether only lifestyle modification treatment is necessary.”

“The benefits of treatment for isolated systolic hypertension among the elderly has been proven, but such evidence does not exist for younger and middle-aged adults,” the study said.

“Further research is warranted, including clinical trials and studies seeking better ways (e.g., central BP monitoring, biomarkers) to identify younger and middle-aged adults with isolated systolic hypertension who are at especially greater risk for developing cardiovascular events,” the study said.

For more information:

Related Content

HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG| August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging| August 18, 2017
August 18, 2017 — The American Society of...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG| August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
New Study Focuses on Protein Responsible For Increased Heart Disease Risk
News | Cardiac Diagnostics| August 03, 2017
August 3, 2017 — A study to reduce the strongest inherited...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Philips released a new version of its iFR system that displays FFR readings as an overlay on live angiographic, angiogram images.

Philips released a new version of its iFR system that displays hemodynamic pressure drop points in an overlay on live angiographic images, matching up the iFR readings with corresponding lesions. The system is supposed to speed diagnostic decision making and help guide percutaneous revascularization procedures. 

Feature | FFR Catheters| July 31, 2017 | Dave Fornell
The gold standard for assessing the hemodynamic significance of coronary lesions to determine if they should be revas
Siemens Healthineers to Acquire Epocal from Alere
News | Point of Care Testing| July 26, 2017
Siemens Healthineers has entered into a definitive agreement to acquire Epocal Inc., a subsidiary of Alere Inc. Epocal...
New PET-CT Scan Improves Detection in Rare Cardiac Condition
News | PET-CT| July 25, 2017
Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests,...
Overlay Init